Cargando…

Anti-IgE monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review

Mostrar otras versiones (1)

BACKGROUND: Several options are available for the treatment of chronic rhinosinusitis (CRS), but disease control remains elusive for many patients. Recently, literature has emerged describing anti-IgE monoclonal antibody as a potential therapy for CRS. However, its effectiveness and safety are not w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Chris J., Tsang, Adrian C., Quinn, Jason G., Bonaparte, James P., Stevens, Adrienne, Kilty, Shaun J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652338/ https://www.ncbi.nlm.nih.gov/pubmed/26581392 http://dx.doi.org/10.1186/s13643-015-0157-5

Ejemplares similares

Anti-Ige monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review
por: Hong, Chris J, et al.
Publicado: (2014)

Anti-Ige monoclonal antibody therapy for the treatment of patients with chronic rhinosinusitis: a multi-disciplinary practice review
por: Kilty, Shaun J, et al.
Publicado: (2014)

Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy
por: Kariyawasam, Harsha H, et al.
Publicado: (2020)

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
por: D’Amato, Gennaro, et al.
Publicado: (2007)

Development and characterization of a unique anti‐IgE mouse monoclonal antibody cross‐reactive between human and canine IgE
por: Kumagai, Akiko, et al.
Publicado: (2021)

Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE(+) B cells
por: Hu, Jiayun, et al.
Publicado: (2018)

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE
por: Zghaebi, Mohammed, et al.
Publicado: (2021)

Human Monoclonal IgE Antibodies—a Major Milestone in Allergy
por: Smith, Scott A., et al.
Publicado: (2022)

Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
por: D’Amato, Gennaro, et al.
Publicado: (2014)

Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)

“Auto-anti-IgE”: Naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation
por: Chan, Yih-Chih, et al.
Publicado: (2014)

Mimicry of human IgE epitopes by anti-idiotypic antibodies
por: Vogel, Monique, et al.
Publicado: (2000)

Regulation of IgE activity in inhalational tolerance via formation of IgG anti-IgE/IgE immune complexes
por: Bracken, Sonali J., et al.
Publicado: (2018)

IgE-Related Chronic Diseases and Anti-IgE-Based Treatments
por: Navinés-Ferrer, Arnau, et al.
Publicado: (2016)

The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
por: Orengo, J. M., et al.
Publicado: (2018)

Primary structure of IgE monoclonal antibodies expressing an intrastrain crossreactive idiotype
Publicado: (1986)

CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells
Publicado: (1990)

Self-reactive IgE and anti-IgE therapy in autoimmune diseases
por: Olewicz-Gawlik, Anna, et al.
Publicado: (2023)

Frequency of IgE-dependent hypersensitivity to moulds in patients with chronic rhinosinusitis with polyps
por: Gawlik, Radosław, et al.
Publicado: (2014)

Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody
Publicado: (1996)

IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance via Fc Receptors
por: Plattner, Kevin, et al.
Publicado: (2022)

Current and future applications of the anti-IgE antibody omalizumab
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab
por: Davies, Anna M., et al.
Publicado: (2017)

Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti‐IgE/IgE immune complexes
por: Bundhoo, A., et al.
Publicado: (2015)

Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells
por: Nyborg, Andrew C, et al.
Publicado: (2016)

A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab
por: Okude, Azusa, et al.
Publicado: (2012)

Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) in Pediatric Severe Allergic Asthma—A Romanian Perspective
por: Berghea, Elena Camelia, et al.
Publicado: (2021)

Serum levels of specific IgE to Staphylococcus aureus enterotoxins in patients with chronic rhinosinusitis
por: CUI, XIN-YAN, et al.
Publicado: (2015)

Clinical Significance of Cytoplasmic IgE-Positive Mast Cells in Eosinophilic Chronic Rhinosinusitis
por: Gion, Yuka, et al.
Publicado: (2020)

Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments
por: McCraw, Alex J., et al.
Publicado: (2021)

Advances in Anti-IgE Therapy
por: Yalcin, Arzu Didem
Publicado: (2015)

Human IgE monoclonal antibody recognition of mite allergen Der p 2 defines structural basis of an epitope for IgE cross-linking and anaphylaxis in vivo
por: Khatri, Kriti, et al.
Publicado: (2022)

Inhibition of IgE Activity to Bind its High Affinity Receptor (FcεRIα) by Mouse Anti-IgE Cε3∼4 Monoclonal Antibody (QME5)
por: Qiao, Chun Xia, et al.
Publicado: (2009)

Oral immunotherapy and anti-IgE antibody treatment for food allergy
por: Umetsu, Dale T., et al.
Publicado: (2015)

Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies
por: Hanittinan, Oranicha, et al.
Publicado: (2022)

Canadian guidelines for rhinosinusitis: practical tools for the busy clinician
por: Kilty, Shaun
Publicado: (2012)

Tuning IgE: IgE-Associating Molecules and Their Effects on IgE-Dependent Mast Cell Reactions
por: Ando, Tomoaki, et al.
Publicado: (2021)

Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

IgE Antibodies against Cancer: Efficacy and Safety
por: Chauhan, Jitesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rv8hmtuc0vnuu60p7s77q40g9